Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
LUF7445/A2A antagonist (AC136)
Cat.#: ASSD-136
Specifications
Description A2A antagonist. Binds irreversibly. Apparent pKi values at A2ARs are 8.27 (after 0.5h) and 8.99 (after 3h), where a Ki shift indicates a covalent mode of action. Size 50 μg Chemical Name 4-[3-[[7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino]propylcarbamoyl]benzenesulfonyl fluoride Molecular formula C18H17FN8O4S PubChem identifier 145958874 Purity >95% Solubility Soluble in DMSO Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-194 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) 100 mg inquiry ASSD-110 Picro Sirius Red Stain Kit (AC110) 1 kit, 100 tests inquiry ASSD-170 BAPTA-AM (AC170) 25 mg inquiry ASSD-104 Hoechst 33258 (AC104) 25 mg, 100 mg inquiry ASSD-215 1-Pyrenylmethyl Methanethiosulfonate (AC215) 10 mg inquiry ASSD-226 Antifade Fluorescence Mounting Medium (hard set) (AC226) 10 mL inquiry ASSD-107 Modified Mayer's Hematoxylin (AC107) 125 mL, 250 mL, 2×250mL inquiry ASSD-211 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) 100 mg, 1 g inquiry ASSD-144 Oxazole Yellow Iodide (AC144) 1 mg inquiry ASSD-102 DAPI (AC102) 10 mg, 50 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket